ClinicalTrials.Veeva

Menu

Expressiona and Diagnostic Potential of miRNAs in NSCLC

A

Al-Azhar University

Status

Completed

Conditions

Non Small Cell Lung Cancer

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT05815407
FOP AlAzharU

Details and patient eligibility

About

Its to explore the expression pattern, diagnostic and prognostic potentials of miRs (106b-5p, 601 and 760) in serum of NSCLC patients

Full description

A retrospective observational study on NSCLC patients, to determine the serum expression levels if some miRNAs in NSCLC patients and to find if having proper diagnostic and prognostic values in early disease detection, and/or staging.

Enrollment

100 patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • First time and recently diagnosed NSCLC patient

Exclusion criteria

  • Recurrent NSCLC
  • Start of chemotherapy, radiotherapy or surgical intervention
  • Previous treatment
  • Cancer history

Trial design

100 participants in 2 patient groups

NSCLC patients
Description:
Patients were diagnosed with NSCLC at any stage, then will be subdivided into Early stage, Lympho-node involvement stage and Distant metastatic stage
Treatment:
Other: No intervention
Control subjects
Description:
Appearantly healthy age-matched individuals
Treatment:
Other: No intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems